Literature DB >> 23345305

Discussion of 'small-sample behavior of novel phase I cancer trial designs' by Assaf P Oron and Peter D Hoff.

Bradley P Carlin1, Wei Zhong, Joseph S Koopmeiners.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23345305      PMCID: PMC4085677          DOI: 10.1177/1740774512469313

Source DB:  PubMed          Journal:  Clin Trials        ISSN: 1740-7745            Impact factor:   2.486


× No keyword cloud information.
  1 in total

1.  A trivariate continual reassessment method for phase I/II trials of toxicity, efficacy, and surrogate efficacy.

Authors:  Wei Zhong; Joseph S Koopmeiners; Bradley P Carlin
Journal:  Stat Med       Date:  2012-07-16       Impact factor: 2.373

  1 in total
  1 in total

1.  The Randomized CRM: An Approach to Overcoming the Long-Memory Property of the CRM.

Authors:  Joseph S Koopmeiners; Andrew Wey
Journal:  J Biopharm Stat       Date:  2017-03-25       Impact factor: 1.051

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.